Ho Mao-Wang, Li Te-Mao, Li Ju-Pi, Chiou Jian-Shiun, Chiu Mu-Lin, Chen Chao-Jung, Cheng Chi-Fung, Tsai Fuu-Jen, Wu Yang-Chang, Lin Ting-Hsu, Liao Chiu-Chu, Huang Shao-Mei, Lin Yu-Ning, Chou Chen-Hsing, Liang Wen-Miin, Lin Ying-Ju
Section of Infectious Diseases, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
Department of Internal Medicine, School of Medicine, China Medical University, Taichung, Taiwan.
Front Pharmacol. 2021 Apr 16;12:593434. doi: 10.3389/fphar.2021.593434. eCollection 2021.
The survival of patients with HIV has greatly improved, due to Anti-Retroviral Therapy (ART). However, long-term HIV survivors often develop serious bone abnormalities, possibly due to the interplay of osteoblasts, osteoclasts, HIV ad ART. We evaluated in a nation-wide study in Taiwan the effect of Chinese herbal medicine (CHM) on overall mortality in HIV patients with osteoporosis or fractures. Enrollment period was between 1998 and 2011. Patients with osteoporosis or fractures before the HIV infection, and those with less than 14 days CHM use, were excluded. This left 498 patients, 160 CHM users, 338 without CHM. Univariate Kaplan-Meier and multivariate Cox regression analysis were used to compare the overall mortality in these 2 groups. Due to the nature of Chinese medicine, CHMs inevitably varied. We therefore also used rule mining and network analysis to determine which major CHM clusters were prescribed to the patients. CHM users had a much Lower mortality (hazard ratio (HR) = 0.43, 95% confidence interval (CI): 0.24-0.77, < 0.005) and higher survival ( = 0.004, log-rank test). Although the CHMs greatly varied, network analysis identified one main cluster of strongly related CHM combinations (Chuan-Xiong-Cha-Tiao-San (CXCTS), Gan-Cao (GC; .), Liu-He-Tang (LHT), Huang-Qin-Tang (HQT), Jia-Wei-Ping-Wei-San (JWPWS), and Dang-Gui-Long-Hui-Wan (DGLHuiW)). CHM as an additional treatment strongly improves overall survival in HIV-infected patients with osteoporosis and fractures.
由于抗逆转录病毒疗法(ART),艾滋病病毒(HIV)患者的生存率有了显著提高。然而,长期的HIV幸存者常常会出现严重的骨骼异常,这可能是由于成骨细胞、破骨细胞、HIV和ART之间的相互作用所致。我们在台湾进行了一项全国性研究,评估了中药(CHM)对患有骨质疏松症或骨折的HIV患者总体死亡率的影响。入组时间为1998年至2011年。排除HIV感染前患有骨质疏松症或骨折的患者,以及使用中药少于14天的患者。最终留下498名患者,其中160名使用中药,338名未使用中药。采用单变量Kaplan-Meier法和多变量Cox回归分析比较这两组患者的总体死亡率。由于中药的性质,中药不可避免地存在差异。因此,我们还使用规则挖掘和网络分析来确定给患者开的主要中药集群。使用中药的患者死亡率低得多(风险比(HR)=0.43,95%置信区间(CI):0.24-0.77,P<0.005),生存率更高(P=0.004,对数秩检验)。尽管中药差异很大,但网络分析确定了一组主要的密切相关中药组合(川芎茶调散(CXCTS)、甘草(GC)、六合汤(LHT)、黄芩汤(HQT)、加味平胃散(JWPWS)和当归龙荟丸(DGLHuiW))。中药作为一种辅助治疗方法,能显著提高感染HIV且患有骨质疏松症和骨折患者的总体生存率。